SynBalance Srl is pleased to announce that it has won two prestigious NutraIngredients Awards at the ceremony held on May 15, 2024, in Geneva. The company was honored with the Ingredient of the Year award in the Microbiome Modulation category for its product SynbÆctive® Femme, and SynbÆctive® ProBeautyShield won the Ingredient of the Year award in the Beauty from Within category.
“We are honored to receive these awards from such a prestigious organization,” said Cristiana Piangiolino, Managing Director at SynBalance Srl. “These awards are a testament to our commitment to developing innovative and science-backed probiotic ingredients.”
The NutraIngredients Awards are recognized as one of the leading award programs in the nutraceutical industry. A panel of independent experts evaluates the awards, assessing products based on innovation, scientific evidence, and market potential.
SynbÆctive® Femme
SynbÆctive® Femme won the Ingredient of the Year award in the Microbiome Modulation category due to its clear market positioning and ongoing efforts to enhance the scientific evidence supporting its claims. The judges highlighted the product’s ability to modulate the microbiome effectively and its strong foundation in scientific research.
SynbÆctive® ProBeautyShield
SynbÆctive® ProBeautyShield was awarded the Ingredient of the Year award in the Beauty from Within category for its well-presented case that excelled in all judging criteria. The product combines three strains of bacteria with anti-aging and anti-inflammatory effects, backed by three clinical trials published in reputable journals. The judges noted its strong relevance to the market, clear consumer demand, and commercial success.
About SynBalance Srl
SynBalance develops and studies proprietary probiotic strains belonging to Lactobacilli and Bifidobacteria as ingredients, available in branded or customized formulations, or as white label products. Its mission is to provide clinically proven probiotics and other microbiome-related technologies to promote health through the prevention of chronic diseases and aging. SynBalance’s portfolio targets various health functions, including women’s health, gut-skin axis, mental health, cardiovascular prevention, and immune system support, through sustainable modulation of the intestinal microbiota. SynBalance’s versatile business model supports customers with a focus on efficacy, competitiveness, and time-to-market.
Content Sponsored by SynBalance
